Additionally, the TGF-β pathway was found to upregulate CLDN4 expression and enhance GBM cell invasiveness, while its inhibition by ITD-1 reduced CLDN4 levels and suppressed invasion. The gene discussed is CLDN4; the disease is glioblastoma.